Want to see JP:2267 full AI Analyst Report?
2267 Stock Chart & Stats
¥2402.00
-¥34.50(-1.18%)
At close: 4:00 PM EST
¥2402.00
-¥34.50(-1.18%)
Day’s Range― - ―
52-Week Range¥2,291.00 - ¥3,092.00
Previous CloseN/A
Volume1.27M
Average Volume (3M)2.74M
Market Cap
¥828.80B
Enterprise Value¥740.66K
Total Cash (Recent Filing)¥217.05B
Total Debt (Recent Filing)¥113.01B
Price to Earnings (P/E)17.9
Beta0.16
Next Earnings
Nov 17, 2026EPS Estimate
47.03Next Dividend Ex-DateN/A
Dividend Yield2.26%
Share Statistics
EPS (TTM)158.39
Shares Outstanding302,753,720
10 Day Avg. Volume1,698,770
30 Day Avg. Volume2,742,059
Financial Highlights & Ratios
PEG Ratio110.66
Price to Book (P/B)1.29
Price to Sales (P/S)1.60
P/FCF Ratio-59.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)165.19
Revenue Forecast (FY)¥507.87B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a growing equity base provide financial resilience, reduce dependence on external funding, and give Yakult flexibility to sustain operations or invest through periods of weaker profitability.
Strong Gross MarginsPersistently high gross margins indicate meaningful product economics and provide a buffer against cost pressure. This supports the durability of the probiotic beverage model if operating expenses can be controlled.
Recurring Global DistributionA multi-channel model combining recurring household delivery, retail access and international operations broadens customer reach. Geographic and channel diversification can support resilience beyond any single market or distributor.
Bears Say
Operating Margin CompressionThe sharp margin decline signals weaker operating leverage or higher costs and reduces current earnings power. If sustained, it could constrain reinvestment capacity and weaken returns despite the company remaining profitable.
Revenue ContractionNegative revenue growth indicates that demand or market expansion did not offset underlying pressures in the latest period. Persistent stagnation would make it harder to absorb fixed costs and restore prior operating margins.
Negative Free Cash FlowA reversal to negative free cash flow reduces near-term financial flexibility and may reflect heavier investment, working-capital pressure or weaker cash conversion. Continued weakness could limit funding available for growth and shareholder returns.
Yakult Honsha Co News
2267 FAQ
What was Yakult Honsha Co Ltd’s price range in the past 12 months?
Yakult Honsha Co Ltd lowest stock price was ¥2291.00 and its highest was ¥3092.00 in the past 12 months.
What is Yakult Honsha Co Ltd’s market cap?
Yakult Honsha Co Ltd’s market cap is ¥828.80B.
When is Yakult Honsha Co Ltd’s upcoming earnings report date?
Yakult Honsha Co Ltd’s upcoming earnings report date is Nov 17, 2026 which is in 90 days.
How were Yakult Honsha Co Ltd’s earnings last quarter?
Yakult Honsha Co Ltd released its earnings results on Jul 31, 2026. The company reported ¥46.99 earnings per share for the quarter, beating the consensus estimate of ¥25.427 by ¥21.563.
Is Yakult Honsha Co Ltd overvalued?
According to Wall Street analysts Yakult Honsha Co Ltd’s price is currently Overvalued.
Does Yakult Honsha Co Ltd pay dividends?
Yakult Honsha Co Ltd pays a Semiannually dividend of ¥36 which represents an annual dividend yield of 2.26%. See more information on Yakult Honsha Co Ltd dividends here
What is Yakult Honsha Co Ltd’s EPS estimate?
Yakult Honsha Co Ltd’s EPS estimate is 47.03.
How many shares outstanding does Yakult Honsha Co Ltd have?
Yakult Honsha Co Ltd has 302,753,720 shares outstanding.
What happened to Yakult Honsha Co Ltd’s price movement after its last earnings report?
Yakult Honsha Co Ltd reported an EPS of ¥46.99 in its last earnings report, beating expectations of ¥25.427. Following the earnings report the stock price went down -2.894%.
Which hedge fund is a major shareholder of Yakult Honsha Co Ltd?
Currently, no hedge funds are holding shares in JP:2267
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yakult Honsha Co Ltd
Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the manufacturing and sale of a broad array of products, including food and beverages, cosmetics, and pharmaceuticals. The company's operations are segmented geographically for its Food and Beverages division, covering Japan, the Americas, Asia and Oceania, and Europe, alongside dedicated Pharmaceutical and "Others" segments. Its extensive food and beverage offerings feature popular items such as fermented milk beverages, various juices, and noodle products, which are distributed through both a home delivery service and traditional retail channels. In the pharmaceutical sector, Yakult Honsha provides specific medications like the antineoplastic drug Elplat, along with a suite of generic anti-cancer treatments, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Furthermore, the company maintains a presence in the cosmetics industry and is notably the owner of the professional baseball team, the Tokyo Yakult Swallows. Founded in 1935, Yakult Honsha Co.,Ltd. is headquartered in Tokyo, Japan.
2267 Company Deck
2267 Earnings Call
Q4 2026
0:00 / 0:00
Technical Analysis
ITO EN
―
Meiji Holdings Co
―
Suntory Beverage & Food
―
Morinaga Milk Industry Co., Ltd.
―
DyDo Group Holdings, Inc.
―